About us and our product, CARDIUX

Trulli
  • Our company is primarily founded with the aim to develop smart IOT enabled wearable devices that will detect and monitor various cardio-vascular anomalies, with a high degree of precision, at an affordable cost.
  • Our product, CARDIUX (our Trade Mark Right) , is a wearable device that can remotely ( sitting in house or workplace) monitor hemodynamic & other cardiovascular vital parameters of a patient to enable doctors to act early before emergencies actually occur, there by reducing time & cost of treatment.
  • Why CARDIUX ? –CVD (Cardiovascular Disease) comprise 33% of global deaths. Low & Middle income countries like India account for 80% of total CVD deaths. In perspective of India’s disjointed healthcare ecosystem, for a medical emergency, the reaction time to life-saving treatment is much more, thus cost goes higher and lives are lost. A proactive, ubiquitous platform like CARDIUX aims to disrupt that. It is an Impending Necessity for India.

Why CARDIUX is Unique?

  • As an holistic wearable belt, CARDIUX, can predict up to 90% of medical emergencies by picking up early trends of vital parameters (as early as 100 days before any actual emergency occurring). Predictable emergencies include almost all cardiovascular, pulmonary & associated emergencies.
  • Data gets transmitted to doctors on a real-time basis via BLE for earliest diagnosis & intervention. Data can also be stored in memory card for late reviews. Emergency contacts of patients will also be in the loop.
  • Our android application will have an ARTIFICIAL Intelligence(AI) based color-coded(RED, YELLOW , ORANGE, GREEN-‘RECOMMENDATION BOT’ that will act further as an early warning predictive engine by suggesting specific danger level of the user& action required.
  • CARDIUX involves unique technology, Impedance Cardiography (ICG) which can grade the stages of heart failure by quantifying pulmonary edema (abnormal fluid in lungs/Thoracic fluid content/TFC).
  • A guiding tool, CARDIUX is certified by ERTL to have an exact and atpar accuracy with FDA -approved clinical device (BIOPAC).

Cardiux-Parameters, scope & competition

Parameters:

  • Heart Rate
  • Heart Rate variability(HRV)
  • ECG
  • TFC by ICG
  • PPG(Oxygen saturation/SPO2)
  • Cuffless Blood Pressure
  • Body temperature
  • Respiration rate

Scope:

  • Cardiux will play a pivotal role in Geriatric and Home Health Care.
  • Combined with Telemedicine facilities, it will be functioning as a ‘virtual ICU’
Trulli

Founding Partners

partner image 1

JOYDIP CHAUDHURI

B.TECH

partner image 1

RATNADIPA BANERJEE

MBBS(CAL), DNB(PATH)